Religare Enterprises growth ratios

·Banking & FinanceChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+15.0%+18.0%+33.3%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−54.8%−5.8%−31.8%
−62.7%−3.5%−40.0%
−60.1%−47.2%−89.0%
−31.7%−46.8%−92.6%
+29.2%+17.2%+18.3%
+12.8%+8.3%+18.6%
+15.8%+4.8%−0.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

RELIGARE₹216.14

Religare Enterprises Ltd.

· Banking & Finance
₹ CrorePeersSTARHEALTHPSBPRUDENTSHAREINDIASOUTHBANKSTYLMAHSCOOTERTMBMcap ₹7,173 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—+33.3+18.0+15.0—
EBITDA Growth—-31.8-5.8-54.8—
EBIT Growth—-40.0-3.5-62.7—
Net Income Growth—-89.0-47.2-60.1—
EPS Growth—-92.6-46.8-31.7—
Total Assets Growth—+18.3+17.2+29.2—
Total Equity Growth—+18.6+8.3+12.8—
Cash from Operations Growth—-0.4+4.8+15.8—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.